Published 6 days ago • loading... • Updated 6 days ago

Hagens Berman Sobol Shapiro LLP and Lowey Dannenberg, P.C. Announce Certification of a Class of Third Party Payors Who Purchased or Paid for Some or All of the Price of Stelara

On Dec. 8, 2025 the court certified a class action for Third-Party Payors in CareFirst of Maryland v. Johnson & Johnson pending in the Eastern District of Virginia.
Plaintiffs allege Johnson & Johnson engaged in a patent scheme using the '307 and Momenta patents to delay Stelara biosimilars by at least fifteen months, inflating prices and seeking damages.
The class period runs from January 1, 2024 through December 31, 2025, with a trial set for January 26, 2026 at Walter E. Hoffman United States Courthouse, Norfolk, Virginia.
Class members who do nothing remain in the Class and may be bound by court orders, there is no money currently available, and any attorneys' fees and costs would come from any recovery.
Excluded entities include Johnson & Johnson , federal and state governmental entities, and Medicaid-only Third-Party Payors ; the Damages Class covers TPP purchases in specified states and territories, with details at StelaraTPPClassAction.com or A.B. Data, Ltd.

Insights by Ground AI